Our site uses cookies necessary for its proper functioning. To improve your experience, other cookies may be used: you can choose to disable them. This can be changed at any time via the Cookies link at the bottom of the page.


16-18 October 2024

We are sorry to announce that registrations are closed.

The maximum amount of attendees has been reached.

Brain-Nutrition interactions:
From metabolic to psychiatric and neurodegenerative diseases

Eating hypercaloric food, rich in saturated fats and sugars and lacking essential nutrients, vitamins, and fibers, is associated with brain non-communicable diseases, including depression, anxiety, Alzheimer’s, and Parkinson’s, often co-morbid with obesity and type-2 diabetes. Complex intertwining exists between these different pathologies and our diet. An appropriate energy supply in quantity and quality is crucial for healthy brain functioning. Consequently, the brain is the main victim of changes in diet-induced energy disposal and metabolism, ultimately leading to pathology. On the other hand, nutrients and micronutrients represent potential tools to protect/correct brain diseases, and can be used to design new nutritional strategies for personalized medicine.

This conference will gather recognized French and International experts, who will provide overviews on advances made in understanding the impact of nutrition on psychiatric, neurodegenerative, and metabolic disorders, from molecular to behavioral neuroscience, up to human clinical trials and interventions. Presentations from established scientists will be combined with short talks and posters from younger researchers. The speakers’ list includes young and more experienced scientists, respecting diversity and gender balance.



  • Richard Bazinet, University of Toronto, Canada
  • Nicholas Betley, University of Pennsylvania, USA
  • Frédéric Calon, Université de Laval, Québec
  • Lucile Capuron, INRAE, University of Bordeaux, France
  • John Cryan, University College Cork, Ireland
  • Marcelo Dietrich, Yale University, USA
  • Joel Doré, INRAE, University of Paris-Saclay, France
  • Sadaf Farooqi, University of Cambridge, UK
  • Cristina Garcia-Caceres, Helmholtz Zentrum Muenchen, Institute for Diabetes and Metabolism, Germany
  • Tatiana Korotkova, University of Köln, Max Planck Institute for Metabolism Research, Germany
  • Sophie Leclercq, Université catholique de Louvain, Belgium
  • Serge Luquet, CNRS, University of Paris, France
  • Michel Neunlist, Inserm, University of Nantes, France
  • Sophie Nicklaus, INRAE, Univiersity of Dijon, France
  • Soyoung Park, DIFE, Germany
  • Vincent Prevot, INSERM, University of Lille, France
  • David Rubinsztein, University of Cambridge, UK
  • Cécilia Samieri, Univeristy of Bordeaux, France
  • Sandrine Thuret, King's College London, UK
  • Matthias Tschöp, Helmholtz Zentrum Muenchen, Germany 

Scientific committee

  • Daniela Cota, Inserm, Neurocentre Magendie
  • Benjamin Dehay, Inserm, Institut des Maladies Neurodégénératives
  • Xavier Fioramonti, Inrae, NutriNeuro
  • Sophie Layé, Inrae, NutriNeuro
  • Carmelo Quarta, Inserm, Neurocentre Magendie


They are supporting us

This project has received financial support from the French government within the framework of the France 2030 programme IdEx université de Bordeaux.